可能因为您的浏览器不支持样式,您可以更新您的浏览器到最新版本,以获取对此功能的支持,访问下面的网站,获取关于浏览器的信息:
[1]黄从新,张 澍,马长生,等.心房颤动:目前的认识和治疗建议—2012[J].中华心律失常学杂志,2012,16(4):246-289.
[2]周自强,胡大一,陈 捷,等.中国心房颤动现状的流行病学研究[J].中华内科杂志,2004,43(7):491-494.
[3]Han J,Cheng J,mathuria N,et al.Phamacologic and nonpharmacologic therapies for stroke prevention innonvalvular atrial fibrillation[J].Pacing Clin Electrophysiol,2012,35(7):887-896.
[4]January CT,Wann LS,Alpert JS,et al.2014 AHA/ACC/HRS guideline for the management of patients with atrial fibrillation : a report of the American College of Cardiology/American Heart Association Task Force on Practice Guideline and the Heart Rhythm Society[J].J Am Coll Cardiol,2014,64(21):e1-e76.
[5]Ono A,Fujita T.Stroke prevention in patients with atrial fibrillation[J].J Clin Neurosci,2003,10(1):71-73.
[6]Onalan O,Crystal E.Left atrial appendage exclusion for stroke prevention in patients with nonrheumatic atrial fibrillation[J].Stroke,2007,38(2 suppl):624-630.
[7]Salzberg SP,Plass A,Emmert MY,et al.Left atrial appendage clip occlusion: early clinical results[J].J Thorac Cardiovasc Surg,2010, 139(5):1269-1274.
[8]Reddy VY,Doshi SK,Sievert H,et al.Percutaneous left atrial appendage closure for stroke prophylaxis in patients with atrial fibrillation:2.3-year follow-up of the PROTECT AF(Watchman Left Atrial Appendage System for Embolic Protection in patients with atrial fibrillation)trial[J].Circulation,2013,127(6):720-729.
[9]Holmes DR Jr,Kar S,Price MJ,et al.Prospective randomized evaluation of the Watchman Left Atrial Appendage Closure device in patients with atrial fibrillation versus long-term warfarin therapy:the PREVAIL trial[J].J Am Coll Cardiol,2014,64(1):1-12.
[10]Reddy VY,Mobius-Winkler S,Miller MA,et al.Left atrial appendage closure with the Watchman device in patients with a contraindication for oral anticoagulation:the ASAP study(ASA Plavix Feasibility Study with Watchman Left Atrial Appendage Closure Technology)[J].J Am Coll Cardiol,2013,61(25):2551-2556.